Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Journal of Medical Microbiology|June 12, 2025
Assessing the impact of common pain medications on gut microbiota composition and metabolites: insights from a Mendelian randomization studyFeng Wei, Diefei Liang, Junxiong Qiu, et al.
Cardiology|March 6, 2019
Association of miR-197-5p, a Circulating Biomarker for Heart Failure, with Myocardial Fibrosis and Adverse Cardiovascular Events among Patients with Stage C or D Heart FailureWei Liu, Junmeng Zheng, Jianzeng Dong, et al.
Frontiers in Pharmacology|April 4, 2025
Navarixin alleviates cardiac remodeling after myocardial infarction by decreasing neutrophil infiltration and the inflammatory responsePeikun Hu, Wei Liu, Jungang Huang, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|November 13, 2022
USP14-mediated NLRC5 upregulation inhibits endothelial cell activation and inflammation in atherosclerosisYuan Fu, Junxiong Qiu, Jianhua Wu, et al.
Frontiers in Cardiovascular Medicine|October 3, 2022
Machine learning-based prediction of the post-thrombotic syndrome: Model development and validation studyTao Yu, Runnan Shen, Guochang You, et al.
Theranostics|May 14, 2025
Nuclear damage-induced DNA damage response coupled with IFI16-driven ECM remodeling underlies dilated cardiomyopathyQingyong He, Xing Chang, Hui Zhang, et al.
Acta Pharmaceutica Sinica. B|December 13, 2021
Ablation of Akt2 and AMPKα2 rescues high fat diet-induced obesity and hepatic steatosis through Parkin-mediated mitophagyShuyi Wang, Jun Tao, Huaguo Chen, et al.
International Journal of Medical Sciences|January 3, 2024
Altered Gut Microbiota as a Potential Risk Factor for Coronary Artery Disease in Diabetes: A Two-Sample Bi-Directional Mendelian Randomization StudyZhaopei Zeng, Junxiong Qiu, Yu Chen, et al.
Acta Pharmaceutica Sinica. B|March 6, 2023
Erratum: Author correction to 'Ablation of Akt2 and AMPKα2 rescues high fat diet-induced obesity and hepatic steatosis through Parkin-mediated mitophagy' [Acta Pharmaceutica Sinica B 11 (2021) 3508-3526]Shuyi Wang, Jun Tao, Huaguo Chen, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 23, 2018
Syndecan-1 as an independent risk factor for the incidence of adverse cardiovascular events in patients having stage C and D heart failure with non-ischemic dilated cardiomyopathyWei Liu, Yuan Wang, Junmeng Zheng, et al.
Pageof 6